Scienture Holdings, Inc.

NasdaqCM SCNX

Scienture Holdings, Inc. Price to Sales Ratio (P/S) on January 15, 2025

Scienture Holdings, Inc. Price to Sales Ratio (P/S) is NA on January 15, 2025, a NA change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • Scienture Holdings, Inc. 52-week high Price to Sales Ratio (P/S) is NA on None, which is NA below the current Price to Sales Ratio (P/S).
  • Scienture Holdings, Inc. 52-week low Price to Sales Ratio (P/S) is NA on None, which is NA below the current Price to Sales Ratio (P/S).
  • Scienture Holdings, Inc. average Price to Sales Ratio (P/S) for the last 52 weeks is NA.
Key data
Date Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield
Market news
NasdaqCM: SCNX

Scienture Holdings, Inc.

CEO Mr. Surendra K. Ajjarapu
IPO Date Feb. 6, 2014
Location United States
Headquarters 6308 Benjamin Rd
Employees 14
Sector Health Care
Industries
Drugstores & Retail Pharmacies Pharmaceuticals Retail & Wholesale
Description

TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.

StockViz Staff

January 15, 2025

Any question? Send us an email